News | May 29, 2021
SMS Pharmaceuticals posts Q4FY21 consolidated PAT of Rs. 22.21 Cr
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
The roller coaster ride during the pandemic has taken Indian pharmaceutical industry through a lot of bitter sweet experiences.
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
The turnover of its NPNC Formulations Division (IKKT Undertaking) for FY 2020-2021 is Rs.21.33 Cr
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
The company has reported total income of Rs.826.40 crores for FY 2020-21
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
The company reported total income of Rs.455.28 crores during the 12 months period ended March 31, 2021
Subscribe To Our Newsletter & Stay Updated
